SCHEMBL1404326

SCHEMBL1404326

NCc1cccc(-c2ccccc2)c1C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 4/20 0.66
DPP4 P27487 2/20 0.66
KMT2A Q03164 1/20 0.51
PTGER1 P34995 1/20 0.45
PTGER4 P35408 1/20 0.45
PTGER3 P43115 1/20 0.45
PTGER2 P43116 1/20 0.45
PDCD1 Q15116 1/20 0.44
CD274 Q9NZQ7 1/20 0.44
HNF4A P41235 1/20 0.44
BCAT2 O15382 1/20 0.43
PTGS2 P35354 1/20 0.41
CYP2C19 P33261 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39
FFAR1 O14842 2/20 0.39
FFAR4 Q5NUL3 2/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8872410 0.85 FOLH1 (0.70) FOLH1DPP4KMT2APTGER1PTGER4
Bicarbonate SCHEMBL27817695 0.85 DPP4 (0.83) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL25181448 0.84 FOLH1 (0.68) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL8949856 0.82 FOLH1 (0.76) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL7109947 0.82 FOLH1 (0.66) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL5033866 0.82 FOLH1 (0.66) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL28001152 0.81 DPP4 (0.59) FOLH1DPP4KMT2APTGER1PTGER4
SCHEMBL469051 0.80 DPP4 (1.00) FOLH1DPP4KMT2APDCD1CD274
SCHEMBL593127 0.80 FOLH1 (0.61) FOLH1KMT2AHNF4ABCAT2CHRNB2
SCHEMBL29872374 0.80 DPP4 (1.00) FOLH1DPP4KMT2APDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2291075-A2 GASTRIN RELEASING PEPTIDE COMPOUNDS Bracco Imaging S.p.A (IT) 2011-03-09 EP disclosed
WO-2009143101-A2 GASTRIN RELEASING PEPTIDE COMPOUNDS BRACCO IMAGING S.P.A. (IT) 2009-11-26 WO disclosed
EP-1585549-A4 IMPROVED GASTRIN RELEASING PEPTIDE COMPOUNDS BRACCO IMAGING SPA (IT) 2009-07-29 EP disclosed
EP-1898962-A1 GASTRIN RELEASING PEPTIDE COMPOUNDS Bracco Imaging, S.P.A. (IT) 2008-03-19 EP disclosed
WO-2007002500-A1 GASTRIN RELEASING PEPTIDE COMPOUNDS BRACCO IMAGING S.P.A. (IT) 2007-01-04 WO disclosed
EP-1585549-A2 IMPROVED GASTRIN RELEASING PEPTIDE COMPOUNDS Bracco Imaging S.p.A. (IT) 2005-10-19 EP disclosed
WO-2004065407-A2 IMPROVED GASTRIN RELEASING PEPTIDE COMPOUNDS BRACCO IMAGING S.P.A. (IT) 2004-08-05 WO disclosed
EP-0610439-B1 PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS AMERICAN HOME PROD (US) 1999-12-15 EP disclosed
EP-0610439-A1 PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 1994-08-17 EP disclosed
US-5234936-A Treating hypertension, congestive heart failure, hyperlipidemia and hypercholesterolemia AMERICAN HOME PRODUCTS CORPORATION (US) 1993-08-10 US disclosed
WO-1993008171-A1 PYRIMIDOCYCLOALKANES AS ANGIOTENSIN II ANTAGONISTS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-04-29 WO disclosed